Doctor Steven Deitelzweig
Ochsner Medical Center, New Orleans (United States of America)
Follow
Contributor content
Presentation
Incidence and delays of a new clinical atrial fibrillation diagnosis following an atrial fibrillation detection signal on a personal electrocardiogram device available to consumers
Presentation
Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
Presentation
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Presentation
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Presentation
Addressing the needs of patients with non-valvular atrial fibrillation and multiple comorbidities: non-vitamin K antagonist oral anticoagulant experience from trials to clinical practice.
Presentation
Real-world evidence complements randomised controlled trial data to inform daily clinical practice.
Presentation
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Presentation
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Presentation
Understanding clinical practice data for anticoagulation in non-valvular atrial fibrillation (NVAF): A scenario-driven discussion of evidence beyond clinical trials.
Presentation
